Jeff Dienhart Named Managing Director of Map of Medicine

Map of MedicineHearst Corporation announced that Jeff Dienhart has been named managing director of Map of Medicine, a subsidiary of Hearst Business Media. Dienhart succeeds Nat Billington, who has decided to leave the company. The appointment was announced today by Frank A. Bennack, Jr., vice chairman and CEO of Hearst Corporation, and Richard P. Malloch, president of Hearst Business Media, and is effective immediately.

Dienhart joins the Map from Groupe Danone, where most recently he was U.K. medical division director, responsible for commercial functions. Dienhart has 17 years of experience with blue-chip life-science companies with a prior background in management consultancy. He has also led various industry and government affairs groups and is the departing British Specialist Nutrition Association (BSNA) Chairman.

"I am very excited that Jeff is joining Map of Medicine," Malloch said. "Map of Medicine's patient pathways, based on the latest clinical evidence, have been used to improve the quality and efficiency of health care in the U.K. Jeff's senior management experience in working across the health care continuum - providers, payers and patients - will be invaluable to the growth of the company."

Regularly used by more than 7,500 clinical staff, Map of Medicine care maps are enabling clinical outcome improvements and productivity savings through local service reconfiguration across a growing range of conditions. Map of Medicine is successfully utilizing its experience gained with clients across the National Health Service (NHS) to simplify services commissioning across care settings, contributing to an improved patient experience. As the NHS faces a period of change, Map of Medicine is well positioned as the solution to address the quality, innovation, productivity and prevention (QIPP) challenge.

"I am delighted to be taking on this new role at this time, as the NHS enters a significant and challenging period of change," Dienhart said. "The Map of Medicine is ideally placed to support the increasing focus on improved productivity and patient outcomes, without sacrificing the overall care environment. We look forward to evolving alongside our health care and IT solutions partners, ensuring that the Map of Medicine's offerings continue to support the design and commissioning of optimum care maps as well as serve as a trusted information resource - leading to the best possible treatment decisions."

Related news articles:

About Map of Medicine
The ideal starting point for defining and communicating services, Map of Medicine is a collection of evidence-based, practice-informed care maps which connect all the knowledge and services around a clinical condition. Map of Medicine care maps can be customised to reflect local needs and practices, offering the opportunity to radically change the way commissioning of health and social care is planned and delivered locally. Map of Medicine is part of Hearst Business Media which is owned by Hearst Corporation, one of the world's largest diversified communications companies. For more information about Map of Medicine, visit www.mapofmedicine.com.

About Hearst Corporation
Hearst Corporation is one of the nation's largest diversified media companies. Its major interests include ownership of 15 daily and 38 weekly newspapers, including the Houston Chronicle, San Francisco Chronicle, San Antonio Express-News and Albany Times Union; nearly 200 magazines around the world, including Good Housekeeping, Cosmopolitan and O, The Oprah Magazine; 29 television stations, which reach a combined 18% of U.S. viewers; ownership in leading cable networks, including Lifetime, A&E, History and ESPN; as well as business publishing, including a minority joint venture interest in Fitch Ratings; Internet and marketing services businesses, television production, newspaper features distribution and real estate.

Most Popular Now

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...